Added to YB: 2020-11-27
Pitch date: 2020-11-27
KPTI:US [bullish]
Karyopharm Therapeutics Inc.
-95.97%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.
Market Cap
$157.4M
Pitch Price
$240.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.54
P/E
-0.48
EV/Sales
2.74
Sector
Biotechnology
Category
N/A
Show full summary:
KARYOPHARM THERAPEUTICS INC COM KPTI:US
A summary for this pitch has not been created yet.
Read full article (0 min)